Zobrazeno 1 - 10
of 268
pro vyhledávání: ''
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 205:495-506
The term "advanced sarcoidosis" is used for forms of sarcoidosis with a significant risk of loss of organ function or death. Advanced sarcoidosis often involves the lung and is described as "advanced pulmonary sarcoidosis" (APS), which includes advan
Publikováno v:
Lung. 199:677-680
Pulmonary hypertension (PH) is associated with decreased survival in patients with pulmonary fibrosis and combined pulmonary fibrosis and emphysema. Main pulmonary artery (PA) diameter and PA diameter/ascending aortic diameter (PA/AA) ratio, as measu
Autor:
Marina Labor, Rocio Garcia, Krzysztof Kowal, Alexander Emelyanov, Guillermo Guidos, Andras Bikov, Ivan Cherrez-Ojeda, Hector Badellino, Paschalis Steiropoulos, Herberto José Chong Neto, Angelica Tiotiu
Publikováno v:
Expert Review of Respiratory Medicine. 15:1035-1048
Introduction: The COVID-19 pandemic has challenged health care across the world, not just by the severity of the disease and the high mortality rate but also by the consequences on the management of the patients with chronic diseases.Areas covered: T
Autor:
Joshua M. Diamond, Jake G. Natalini
Publikováno v:
Seminars in Respiratory and Critical Care Medicine. 42:368-379
Primary graft dysfunction (PGD) is a form of acute lung injury after transplantation characterized by hypoxemia and the development of alveolar infiltrates on chest radiograph that occurs within 72 hours of reperfusion. PGD is among the most common e
Autor:
Hani Alhadidi, Axel Haverich, Christian Kuehn, Reza Poyanmehr, K. Aburahma, Murat Avsar, Jawad Salman, Beeke-Alina Bernhard, Thierry Siemeni, Igor Tudorache, Wiebke Sommer, Gregor Warnecke, Fabio Ius
Publikováno v:
The Annals of Thoracic Surgery. 111:1316-1324
Venous-arterial extracorporeal membrane oxygenation (ECMO) is an established technique for intraoperative cardiopulmonary support in patients undergoing lung transplantation. Patients with pulmonary fibrosis have a higher risk to require it. The aim
Publikováno v:
Respiration. 100:395-403
Background: Combined pulmonary fibrosis and emphysema (CPFE) is a distinct entity among fibrosing lung diseases with a high risk for lung cancer and pulmonary hypertension (PH). Notably, concomitant PH was identified as a negative prognostic indicato
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
Pulmonary Circulation
Pulmonary Circulation
For as long as nucleic acids have been utilized to vertically and horizontally transfer genetic material, living organisms have had to develop methods of recognizing cytosolic DNA as either pathogenic (microbial invasion) or physiologic (mitosis and
Autor:
Haluk Turktas, I. Kivilcim Oguzulgen
Publikováno v:
Tuberk Toraks. 68:419-429
Though it has been 8 months since the beginning of COVID-19 pandemic, number of cases and deaths are still seriously increasing. We still don't have enough evidence about the prognosis of patients who had COVID-19 pneumonia. In long term follow up we
Publikováno v:
Canadian Journal of Respiratory Therapy: CJRT = Revue Canadienne de la Thérapie Respiratoire : RCTR
Background: Interstitial lung diseases (ILDs) include a broad range of diffuse parenchymal lung disorders and are characterized by diffuse parenchymal lung abnormalities leading to irreversible fibrosis. ILDs are correlated with the occurrence of pul
Autor:
Katerina M. Antoniou, Maria Bolaki
Publikováno v:
Seminars in Respiratory and Critical Care Medicine. 41:177-183
Combined pulmonary fibrosis and emphysema (CPFE) is a clinical entity characterized by the combination of upper lobe emphysema and lower lobe fibrosis, the latter owing to various interstitial lung diseases. These patients have a characteristic lung